Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-20-064624

Director bought 10,000 shares at $4.16 ($41,630)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
CONWAY ROBERT E Director 2020-12-18 Purchase +10,000 $4.16 $41,630 30,000 D
Open-market purchases · 10,000 sh · avg $4.16 · $41,630
Loading xslF345X03/doc4.xml…